Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Dr Reddys Laboratories Ltd is down for a fifth straight session today. The stock is quoting at Rs 1245.1, down 1.92% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.88% on the day, quoting at 24172.55. The Sensex is at 77454.26, up 0.93%.Dr Reddys Laboratories Ltd has lost around 2.42% in last one month.Meanwhile, Nifty Pharma index of which Dr Reddys Laboratories Ltd is a constituent, has increased around 5.38% in last one month and is currently quoting at 25656.25, down 0.16% on the day. The volume in the stock stood at 58.42 lakh shares today, compared to the daily average of 21.64 lakh shares in last one month.
The benchmark July futures contract for the stock is quoting at Rs 1250.1, down 0.15% on the day. Dr Reddys Laboratories Ltd tumbled 0.77% in last one year as compared to a 3.89% slide in NIFTY and a 15.25% spurt in the Nifty Pharma index.
The PE of the stock is 34.61 based on TTM earnings ending March 26.
All the sectoral indices in the NSE were traded in green with realty, media and consumer durables shares led the rally.
At 12:26 IST, the barometer index, the S&P BSE Sensex advanced 503.25 points o 0.67% to 77,013.37. The Nifty 50 index rose 157.50 points or 0.65% to 24,036.85.
The broader market outperformed the frontline indices. The BSE 150 MidCap Index rose 1.54% and the BSE 250 SmallCap Index jumped 1.74%.
The market breadth was strong. On the BSE, 2,923 shares rose and 1,138 shares fell. A total of 225 shares were unchanged.
In the commodities market, Brent crude for September 2026 settlement fell 93 cents or 1.19% to $77.09 a barrel.
The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, fell 9.72% to 13.25.
Gainers & Losers:
SBI Life Insurance (up 2.55%), Sun Pharmaceuticals Industries (up 2.56%), Grasim Industries (up 2.46%), Max Healthcare Insitute (up 2.20%) and Shirram Finance (up 2.18%) were the major Nifty50 gainers.
Dr Reddy’s Laboratories (down 5.90%), Maruti Suzuki India (down 1.20%), Infosys (down 1.17%), Eicher Motors (down 1%) and Oil & Natural Gas Corporation of India (ONGC) (down 0.89%) were the major Nifty50 losers.
Stocks in Spotlight:
Premier Energies rallied 4.24% after inaugurating its 5.6 GW solar module manufacturing facility at Seetharampur, Telangana. The company also broke ground for a 6 GWh Battery Energy Storage System (BESS) facility and an 18,000 MT per annum aluminium frames plant.
Antony Waste Handling Cell rose 0.87% after the company reported a serious incident at its waste-to-energy (WtE) facility in Pimpri Chinchwad, Pune. The company said a waste mound outside the plant, destabilised by continuous and exceptionally heavy rainfall, collapsed onto the administration building during the afternoon, causing the structure to cave in.
Dr Reddy's Laboratories tumbled 5.79% after the company said commercial supplies of certain batches of its semaglutide product will be delayed following a quality-related issue involving the active pharmaceutical ingredient (API). Semaglutide is widely used for the treatment of type 2 diabetes and obesity.
The company said certain batches of semaglutide were found to be out of specification due to an issue associated with the API used in the product. It is currently investigating the root cause and taking appropriate corrective measures to ensure product quality.
The Phoenix Mills added 4.95% after the company reported a strong operational performance across its retail, commercial office, hospitality and residential businesses for the quarter ended June 2026 (Q1 FY27). The company's retail portfolio continued to deliver robust growth, with consumption rising 32% year-on-year (YoY) to Rs 4,727 crore during the quarter
Insolation Energy zoomed 13.93% after the company has received a contract worth Rs 558.29 crore, from NTPC Renewable Energy, a wholly owned subsidiary of NTPC. The order involves the supply of solar photovoltaic (PV) modules and is scheduled to be executed during the financial year 2026-27.
Solex Energy jumped 2.21% after the company has received a work order from a leading independent power producer for the manufacture and supply of solar photovoltaic (PV) modules worth Rs 628.37 crore. The order involves the supply of N-Type TOPCon 615 Wp/620 Wp Glass-to-Glass (G12R) solar PV modules. The modules are scheduled to be supplied between October 2026 and March 2027.
Global Markets:
European and Asia market advanced despite renewed U.S.-Iran tensions.
China's annual inflation eased to 1.0% in June 2026 from 1.2% in May, below market expectations of 1.1%, marking the slowest pace in three months. Consumer prices fell 0.3% month-on-month, while core inflation eased to 1.0% YoY.
The U.S. launched fresh strikes on Iran in response to Tehran’s attacks on commercial shipping in and around the Strait of Hormuz, U.S. Central Command said Wednesday afternoon.
Earlier in the day, President Donald Trump said he may no longer be interested in negotiating a deal with Iran. Prior to that, he said that the ceasefire between the U.S. and Tehran is “over” after another wave of attacks in the Middle East.
Overnight on Wall Street, the Dow Jones Industrial Average pulled back from record levels on Tuesday as investors once again appeared to rotate out of names tied to artificial intelligence and as oil prices advanced.
The 30-stock index lost 130.76 points, or 0.25%, after earlier hitting a new all-time intraday high. Ultimately, the Dow closed at 52,925.15. The Nasdaq Composite fell 1.16% to 25,818.69. The S&P 500 slid 0.45% to end at 7,503.85.
Investors are also closely tracking the first-quarter earnings season, with the focus on TCS' Q1 FY27 results due later in the day. Market participants will watch the IT major's management commentary for cues on discretionary technology spending by global clients and the demand outlook for the sector.
Consumer durables shares rebounded after declining in the past trading session.
At 12:25 IST, the barometer index, the S&P BSE Sensex declined 585.92 points o 0.76% to 77,091.46. The Nifty 50 index fell 183.45 points or 0.77% to 24,067.55.
The broader market outperformed the frontline indices. The BSE 150 MidCap Index rose 1.48% and the BSE 250 SmallCap Index jumped 1.64%.
The market breadth was strong. On the BSE, 2,878 shares rose and 1,086 shares fell. A total of 231 shares were unchanged.
In the commodities market, Brent crude for September 2026 settlement fell 30 cents or 0.38% to $77.72 a barrel.
Derivatives:
The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, tumbled 10.43% to 13.15. The Nifty 28 July 2026 futures were trading at 24,103 at a premium of 35.45 points as compared with the spot at 24,067.55.
The Nifty option chain for the 28 July 2026 expiry showed a maximum call OI of 57.3 lakh contracts at the 25,000 strike price. A maximum put OI of 64.1 lakh contracts was seen at the 24,000 strike price.
Buzzing Index:
The Nifty Consumer Durables index jumped 2.01% to 37,957.50. The index declined 1.33% in the past trading session.
Kalyan Jewellers India (up 16.48%), Dixon Technologies (India) (up 4.99%), PG Electroplast (up 2.97%), Amber Enterprises India (up 2.44%), Kajaria Ceramics (up 2.07%) were the top gainers. Among the other gainers were Blue Star (up 1.99%), Whirlpool of India (up 1.24%), Bata India (up 1.02%), LG Electronics India (up 0.9%) and Crompton Greaves Consumer Electricals (up 0.89%) surged.
Dr Reddy's Laboratories tumbled 5.24% after the company said commercial supplies of certain batches of its semaglutide product will be delayed following a quality-related issue involving the active pharmaceutical ingredient (API).
The Phoenix Mills added 3.96% after the company reported a strong operational performance across its retail, commercial office, hospitality and residential businesses for the quarter ended June 2026 (Q1 FY27). The company's retail portfolio continued to deliver robust growth, with consumption rising 32% year-on-year (YoY) to Rs 4,727 crore during the quarter across its existing operational assets.
Dr Reddy's clarified that the issue has no impact on patient safety or the product's existing global regulatory filings. The company added that it remains committed to ensuring reliable global supplies of the metabolic therapy.
The company's management will host a conference call on 9 July 2026 at 4:30 p.m. IST to discuss the development and answer questions from participants.
Hyderabad-based Dr Reddy’s Laboratories is a global pharmaceutical company. It offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC.
The company reported a 86.14% decline in consolidated net profit to Rs 220.9 crore on 11.51% drop in revenue from operations to Rs 7,546.4 crore in Q4 FY26 over Q4 FY25.
JSW Dulux Ltd, Paras Defence and Space Technologies Ltd, Shaily Engineering Plastics Ltd and Solar Industries India Ltd are among the other losers in the BSE's 'A' group today, 09 July 2026.
Dr Reddys Laboratories Ltd tumbled 5.99% to Rs 1267.95 at 14:46 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 3 lakh shares were traded on the counter so far as against the average daily volumes of 87319 shares in the past one month.
JSW Dulux Ltd crashed 3.26% to Rs 2945.9. The stock was the second biggest loser in 'A' group.On the BSE, 1.03 lakh shares were traded on the counter so far as against the average daily volumes of 1610 shares in the past one month.
Paras Defence and Space Technologies Ltd lost 3.20% to Rs 1232.9. The stock was the third biggest loser in 'A' group.On the BSE, 94727 shares were traded on the counter so far as against the average daily volumes of 4.39 lakh shares in the past one month.
Shaily Engineering Plastics Ltd shed 3.10% to Rs 2706.5. The stock was the fourth biggest loser in 'A' group.On the BSE, 18575 shares were traded on the counter so far as against the average daily volumes of 45235 shares in the past one month.
Solar Industries India Ltd plummeted 3.04% to Rs 17412.65. The stock was the fifth biggest loser in 'A' group.On the BSE, 29723 shares were traded on the counter so far as against the average daily volumes of 9074 shares in the past one month.
On 25 June 2026, the drug maker informed the exchanges that the US Food and Drug Administration (USFDA) had completed a Pre-License Inspection (PLI) at its biologics manufacturing facility in Bachupally, Hyderabad. The inspection was conducted between 16 June 2026 and 25 June 2026.
Following the inspection, the USFDA issued a Form 483 with seven observations. Dr. Reddy's said it will respond to the observations within the stipulated timeline.
The company said the inspection is a continuation of earlier inspections and related disclosures made to the stock exchanges on 12 October 2023 and 13 September 2025.
Previously, the USFDA had conducted a Pre-Approval Inspection (PAI) at the same Hyderabad facility between 4 September and 12 September 2025, following which it had issued five observations.
Hyderabad-based Dr. Reddy’s Laboratories is a global pharmaceutical company. It offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC.
The counter advanced 1.63% to settle at Rs 1,350 on Thursday, 25th June 2026. The NSE and BSE remain closed today on account of Muharram.
Dr Reddys Laboratories Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1350.6, up 1.67% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.71% on the day, quoting at 24192.85. The Sensex is at 77548.16, up 0.72%. Dr Reddys Laboratories Ltd has added around 1.71% in last one month.
Meanwhile, Nifty Pharma index of which Dr Reddys Laboratories Ltd is a constituent, has added around 1.66% in last one month and is currently quoting at 25018.95, up 0.2% on the day. The volume in the stock stood at 10.78 lakh shares today, compared to the daily average of 15.46 lakh shares in last one month.
The benchmark June futures contract for the stock is quoting at Rs 1353.9, up 2.07% on the day. Dr Reddys Laboratories Ltd is up 2.2% in last one year as compared to a 5.31% fall in NIFTY and a 14.95% fall in the Nifty Pharma index.
The PE of the stock is 34.44 based on TTM earnings ending March 26.